Blonanserin

This classification denotes a serotonin antagonist with the molecular formula C23H30FN3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, AQ316B4F8C chemically known as 2-(4-ethyl-1-piperazinyl)-4-(p-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine but generally known as blonanserin, which bears US NIH Compound Identifier 125564. European Medicines Agency schedules Blonanserin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05864MIG. The term BLONANSERIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, no. 3 1997, list 38. ). Most nations schedule blonanserin under HS 29335995 and SITC 51576. As of Q4 2014, BLONANSERIN remains the US FDA Preferred Term for this commodity. Blonanserin bears US NLM identifiers UMLS ID C0287983 and NCI Concept Code C95920. SMILES: CCN1CCN(CC1)C2=NC3=C(CCCCCC3)C(=C2)C4=CC=C(C=C4)F.